Ofer Finkelstein
Biographic Data
| ID | 7240865 |
|---|---|
| NAME | Ofer Finkelstein |
| GIVEN NAMES | Ofer |
| FAMILY NAME | Finkelstein |
| SIGNATURE | FINKELSTEIN O |
| AFFILIATIONS | Centre for Addiction and Mental Health |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Beyond Psilocybin
There has been a resurgence of interest in the use of psychedelic therapies for several mental and substance use disorders. Psilocybin, a "classic" serotonergic psychedelic, has emerged as one of the primary compounds of interest in clinical research. While research on psilocybin's potential mental health benefits has grown, data on the safety and efficacy of other serotonergic psychedelics remain limited. A comprehensive scoping review on the us…
No prominent works on this page.
Beyond Psilocybin
There has been a resurgence of interest in the use of psychedelic therapies for several mental and substance use disorders. Psilocybin, a "classic" serotonergic psychedelic, has emerged as one of the primary compounds of interest in clinical research. While research on psilocybin's potential mental health benefits has grown, data on the safety and efficacy of other serotonergic psychedelics remain limited. A comprehensive scoping review on the us…
Anxiety (1 work) · Ayahuasca (1 work) · Chemical synthesis and alkaloids (1 work) · Clinical Psychology (1 work) · Hallucinogen (1 work) · Internal Medicine (1 work) · Lysergic acid diethylamide (1 work) · Medicine (1 work) · Mescaline (1 work) · Mood (1 work)